The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $65.60

Today's change-0.18 -0.27%
Updated July 26 10:09 AM EDT. Delayed by at least 15 minutes.
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $65.60

Today's change-0.18 -0.27%
Updated July 26 10:09 AM EDT. Delayed by at least 15 minutes.

LifePoint Health Inc crosses below 20-day moving average

LifePoint Health Inc is lower today, dropping (U.S.)$0.18 or 0.27% to (U.S.)$65.60 and crossing below its 20-day moving average. Although unchanged over the last five days, shares are down 10.63% for the last year to date. This security has underperformed the S&P 500 by 26.24% during the last year.

Key company metrics

  • Open(U.S.) $65.74
  • Previous close(U.S.) $65.78
  • High(U.S.) $65.91
  • Low(U.S.) $64.92
  • Bid / Ask(U.S.) $65.59 / (U.S.) $65.69
  • YTD % change-10.63%
  • Volume38,255
  • Average volume (10-day)307,942
  • Average volume (1-month)339,486
  • Average volume (3-month)352,804
  • 52-week range(U.S.) $58.20 to (U.S.) $86.94
  • Beta0.82
  • Trailing P/E18.26×
  • P/E 1 year forward17.58×
  • Forward PEG2.66×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.59
Updated July 26 10:09 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.16%

Based on its net profit margin of 3.16%, LifePoint Health Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.23%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1,5811,3711,3101,270
Total other revenue--------
Total revenue1,5811,3711,3101,270
Gross profit553500478470
Total cost of revenue1,028871832801
Total operating expense1,5441,2881,2371,192
Selling / general / administrative356286274263
Research & development--------
Depreciation / amortization86727069
Interest expense (income), net operating--------
Unusual expense (income)1020
Other operating expenses, total35303132
Operating income37837278
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax37877278
Income after tax24554650
Income tax, total13312628
Net income22534446
Total adjustments to net income--------
Net income before extra. items22534446
Minority interest-2-2-2-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22534446
Inc. avail. to common incl. extra. items22534446
Diluted net income22534446
Dilution adjustment--------
Diluted weighted average shares45464646
Diluted EPS excluding extraordinary itemsvalue per share0.491.160.941.00
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.501.160.971.00